How to assess liver function?

Current Opinion in Critical Care

Volumn 16, Issue 2, 2010, Pages 136-141

  Kortgen, Andreas ^a   Recknagel, Peter ^a   Bauer, Michael ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Acute on chronic liver failure; Dynamic; Quantitative liver function tests; Static

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; INDOCYANINE GREEN; SODIUM;

BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DECOMPENSATED LIVER CIRRHOSIS; HUMAN; HYPERBILIRUBINEMIA; LIVER CLEARANCE; LIVER DYSFUNCTION; LIVER EXAMINATION; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER HISTOLOGY; PATIENT MONITORING; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SCLEROSING CHOLANGITIS; SCORING SYSTEM; SODIUM BLOOD LEVEL;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHRONIC DISEASE; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; LIVER; LIVER DISEASES; LIVER FAILURE; LIVER FUNCTION TESTS; PROGNOSIS;

EID: 77952286512     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283361813     Document Type: Review

References (40)

1. Strassburg CP. Gastrointestinal disorders of the critically ill. Shock liver. Best Pract Res Clin Gastroenterol 2003;17:369-381.
2. Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83-96. (Pubitemid 34225974)
3. Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006;3:574-585. (Pubitemid 44489590)
4. Tilney NL, Bailey GL, Morgan AP. Sequential system failure after rupture of abdominal aortic aneurysms: an unsolved problem in postoperative care. Ann Surg 1973;178:117-122.
5. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 1991;19:165-181.
6. Vincent JL, Moreno R, Willatts S, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707-710. (Pubitemid 26254283)
7. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007;45:230-241. (Pubitemid 46144383)
8. Bauer M, Huse K, Settmacher U, Claus RA. The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure. Intensive Care Med 2008;34:640-648.
9. Angus DC, Linde-Zwirble WT, Lidicker J, et al. The epidemiology of sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001;29:1303-1310. (Pubitemid 32641789)
10. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005;33:2194-2201.
11. Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients a prospective multicenter study. Crit Care Med 2007;35:1099-1104. (Pubitemid 46598961)
12. Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009;6:287-295. The authors nicely review 'secondary sclerosing cholangitis', an underrecognized chronic cholestatic biliary disease, characterized by inflammation, obliterative fibrosis of the bile ducts, stricture formation and progressive destruction of the biliary tree, which may complicate sepsis-associated cholestasis, resulting in a rapidly progressive disease with poor outcome.
13. Lorf T, Schnitzbauer AA, Schaefers SK, et al. Prognostic value of the monoethylglycinexylidide (MEGX) -test prior to liver resection. Hepatogastroenterology 2008;55:539-543. (Pubitemid 351741498)
14. Everson GT, Shiffmann ML, Hoefs JC, et al. Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-trial. Aliment Pharm Ther 2009;29:589-601.
15. Stintzing S, Schmitt C, Ocker M, et al. Liver function under interferon/ribavirin therapy of chronic hepatitis C. Hepatogastroenterology 2009;56:462-465. Peginterferon/ribavirin, for eradication of chronic hepatitis C, is associated with early improvement of aminopyrine breath test and galactose elimination capacity as parameters of microsomal and cytosolic liver function, while sorbitol and ICG clearance require 1 year of treatment before returning to normal levels, indicating that diverse 'dynamic' liver function tests provide potentially additive information.
16. Miller M, Kahraman A, Ross B, et al. Evaluation of quantitative liver function tests in HIV-positive patients under antiretroviral therapy. Eur J Med Res 2009;14:369-377.
17. Meijer DKF, Weert B, Vermeer GA. Pharmacokinetics of biliary excretion in man. VI indocyanine green. Eur J Clin Pharmacol 1988;35:295-303.
18. Paxian M, Bauer I, Rensing H, et al. Recovery of hepatocellular ATP and 'pericentral apoptosis' after hemorrhage and resuscitation. FASEB J 2003;17:993-1002. (Pubitemid 36676387)
19. Janssen MW, Druckrey-Fiskaaen KT, Omidi L, et al. Indocyanine green R15 ratio depends directly on liver perfusion flow rate. J Hepatobiliary Pancreat Surg 2009 [Epub ahead of print]. doi:10.1007/s00534-009-0160-0.
20. Kortgen A, Silomon M, Pape-Becker C, et al. Thoracic but lumbar epidural anaesthesia increases liver blood flow after major abdominal surgery. Eur J Anaesthesiol 2009;26:111-116.
21. ICG.
22. Eguchi S, Takatsuki M, Yamanouchi K, et al. Indocyanine green dye excretion in bile reflects graft function after living donor liver transplantation. Transplantation 2009;88:747-748.
23. Stockmann M, Malinowski M, Lock JF, et al. Factors influencing the indocyanine green (ICG) test: additional impact of acute cholestasis. Hepatogastroenterology 2009;56:734-738.
24. ICG to assess chronic disease progression and rapid changes of liver perfusion/function in the perioperative setting.
25. Olmedilla L, Perez-Pena JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl 2009;15:1247-1253.
26. ICG.
27. Nishi H, Takahashi T, Ichikawa H, et al. Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart failure. Gen Thorac Cardiovasc Surg 2009;57:357-362.
28. Stehr A, Ploner F, Traeger K, et al. Plasma disappearance rate of indocyanine green: a marker for excretory liver function? Intensive Care Med 2005;31:1719-1722. (Pubitemid 41677250)
29. Kortgen A, Paxian M, Werth M, et al. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock 2009;32:358-365. This article is the first to prospectively assess a broad spectrum of parameters for liver injury, synthesis and excretory function as they relate to prognosis. Furthermore, potential mechanisms for dysfunction are assessed revealing that, although dye excretion is superior to bilirubin to assess excretory dysfunction, it still underestimates the impaired canalicular transport machinery as the primary target of dysfunction in the critically ill.
30. ICG, respectively.
31. Goulding C, Cholongitas E, Nair E, et al. Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. Nephrol Dial Transplant 2009 [Epub ahead of print]. doi:10.1093/ndt/gfp556.
32. Xiol X, Gines P, Castells L, et al. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transplant 2009;15:300-305. In this study, in 70 patients who were waiting for a liver transplant, blood samples were drawn to measure parameters of the MELD and MELDNa scores. Blood samples were processed in three different university laboratories. For all four parameters, that is, bilirubin, creatinine, INR and sodium, there were significant differences between the laboratories, leading to different scores in 64 patients for MELD and 61 patients for MELDNa. Resulting calculated scores differed sometimes by more than 3 points.
33. Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients. J Clin Gastroenterol 2009;43:580-585.
34. Delis S, Bakoyiannis A, Madariaga J, et al. Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc 2009 [Epub ahead of print]. doi:10.1007/s00464- 009-0588-y.
35. Gotthardt D, Weiss KH, Baumgärtner M, et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009;9:72.
36. Murillas J, Rimola A, Laguno M, et al. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transplant 2009;15:1133-1141.
37. Hsu CY, Lin HC, Huang YH, et al. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Digest Liver Dis 2009 [Epub ahead of print]. doi: 10.1016/j.dld.2009.06.004. Two different calculations of a modified MELD score, in which serum sodium concentrations were incorporated in the calculation, demonstrated better mortality prediction than the original MELD score.
38. Bie CQ, Yang DH, Tang SH, Huang W. The value of model for end-stage liver disease and Child-Turcotte-Pugh scores overtime in evaluating the prognosis of patients with decompensated cirrhosis: experience in the Chinese mainland. Hepatol Res 2009;39:770-785.
39. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026. This study demonstrates a better prediction of 90-day mortality with a modified MELD score in a large cohort of patients who were waiting for a liver transplant, which incorporates serum sodium levels. This is important in the light of current discussions regarding graft allocation based on scores, and their potential improvement as score-based allocation has led to lower survival rates compared with waiting list. MELD score and serum sodium levels were significantly associated with mortality. The hazard ratio for death was 1.05 per 1-unit decrease in serum sodium concentration for values between 125 and 140mmol/l.
40. Kortgen A, Hetz H, Morgenthaler NG, et al. Vasoactive mediators in patients with acute liver failure treated with albumin dialysis. Liver Int 2009 [Epub ahead of print]. doi:10.1111/j.1478-3231.2009.02129.x.